VCEL Q2 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+32.2% YoY

Gross Profit

$9M54.8% margin

Operating Income

-$3M-14.9% margin

Net Income

-$2M-14.1% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+81.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$796,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$23M

Stockholders' Equity

$14M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$13M	+32.2%
Gross Profit	$9M	$6M	+68.1%
Operating Income	-$3M	-$5M	+49.4%
Net Income	-$2M	-$3M	+21.6%